How AI and Spatial Biology Are Transforming Cancer Treatment and Clinical Trials
Release Date: 06/19/2025
How AI and Spatial Biology Are Transforming Cancer Treatment and Clinical Trials
Transaction Healthcare
Dusty Majumdar is the CEO of PredxBio, a precision pathology company leveraging AI and spatial biology to transform cancer diagnostics and therapeutics. With over two decades of leadership experience in precision healthcare, he has held senior roles at the American Society of Clinical Oncology, IBM, Exact Sciences, and GE Healthcare. Dusty has spoken at numerous forums, including The Economist War on Cancer and a MIT plenary lecture on AI in healthcare. In this episode… Despite recent advances in cancer research, early detection and effective treatment remain major challenges. Traditional...
info_outline
How Health Law and Policy Shape the Future of Healthcare Transactions
Transaction Healthcare
Christopher (Chris) Raphaely is the Co-chair of the Health Care & Life Sciences Practice Group at Cozen O’Connor, a full-service law firm with practices in litigation, business, and government relations. In his role, he provides transactional and regulatory counsel to various healthcare providers and investors. With nearly three decades of experience in the healthcare industry, Chris specializes in mergers and acquisitions, payer negotiations, HIPAA compliance, and value-based payment arrangements. Before joining Cozen O’Connor, he served as Deputy General Counsel at Jefferson...
info_outline
2025 Healthcare M&A Outlook: Physician Practice Growth, Consolidation, and Equity Insights
Transaction Healthcare
Zak Eisenberg is the Vice President of Merritt Healthcare Advisors, which provides investment banking services to healthcare services organizations. In his role, he manages the strategic development and execution of ASC, surgical hospital, and physician practice transactions. Zak specializes in sourcing and analyzing transactions and capital and negotiating and structuring investments. Previously, he was a Biofund Venture Analyst at New Orleans Bioinnovation Center, a biotech and life science-focused venture capital firm, and led the analysis team at a renewable energy-focused private equity...
info_outline
Creating Patient-Driven Value in a Changing Healthcare Economy
Transaction Healthcare
Zak Eisenberg is the Vice President of Merritt Healthcare Advisors, which provides investment banking services to healthcare services organizations. In his role, he manages the strategic development and execution of ASC, surgical hospital, and physician practice transactions. Zak specializes in sourcing and analyzing transactions and capital and negotiating and structuring investments. Previously, he was a Biofund Venture Analyst at New Orleans Bioinnovation Center, a biotech and life science-focused venture capital firm, and led the analysis team at a renewable energy-focused private equity...
info_outline
The Future of Physician Practices: AI, Consolidation, and Private Equity Insights
Transaction Healthcare
Zak Eisenberg is the Vice President of Merritt Healthcare Advisors, which provides investment banking services to healthcare services organizations. In his role, he manages the strategic development and execution of ASC, surgical hospital, and physician practice transactions. Zak specializes in sourcing and analyzing transactions and capital and negotiating and structuring investments. Previously, he was a Biofund Venture Analyst at New Orleans Bioinnovation Center, a biotech and life science-focused venture capital firm, and led the analysis team at a renewable energy-focused private equity...
info_outline
The Evolving Landscape of Healthcare M&A
Transaction Healthcare
Bart Walker is a Partner at McGuireWoods, an international law firm, and a co-leader of the firm’s healthcare and life sciences industry team. In his role, he focuses on healthcare mergers and acquisitions, strategic joint ventures, and regulatory compliance, advising healthcare providers, private equity sponsors, and lenders. Bart’s clients include hospitals, ambulatory surgery centers, dental service organizations, urgent care providers, and large physician group practices. He has been recognized as an emerging leader in mergers and acquisitions by The M&A Advisor. In this episode…...
info_outline
The Future of Private Practice: Innovation, AI, and Patient Care
Transaction Healthcare
Dr. Michelle Nguyen, MD, is a Gastroenterology Specialist at Unio Specialty Care, a multi-specialty physician practice. As a board-certified gastroenterologist, she has over 15 years of experience specializing in esophageal diseases and quality metrics in colonoscopy. Dr. Nguyen has held leadership positions, including Chief of Gastroenterology in Santa Cruz and an Infusion Site Lead at the Palo Alto Medical Foundation. In this episode… Healthcare professionals often face a difficult choice: stay within large, structured health systems with financial stability or take the leap into...
info_outline
AI in Healthcare: Revolutionizing Pathology With Deep Learning
Transaction Healthcare
Chen Sagiv, PhD, is the Co-founder and Co-CEO of DeePathology, which provides AI solutions for digital pathology. She is also the Co-founder and Co-CEO of SagivTech Ltd., a firm dedicated to image processing, computer vision, and GPU computing. Through her work, Chen empowers pathologists with AI tools to enhance diagnostic accuracy and efficiency. In this episode… The rapid advancements in artificial intelligence are transforming industries, but in healthcare, the stakes are especially high. Physicians, researchers, and entrepreneurs grapple with using AI to enhance diagnostics and...
info_outline
The Future of Healthcare Practices: Navigating Consolidation and Value-Based Care
Transaction Healthcare
John Nantz is the Founding Partner of Redwood Advisors, a firm delivering strategic, organizational, and digital consulting projects to high-growth midsize companies. With over a decade of experience as a management consultant, he has led over 50 consulting projects across various industries, serving clients such as Johnson & Johnson Diabetes Solutions, National Geographic, and NASA Education. Before founding Redwood Advisors, John served as a Business Analyst at McKinsey & Company. In this episode… Outpatient healthcare practices face unique challenges in scaling operations,...
info_outline
The Future of Healthcare M&A: Regulatory Challenges, Private Equity, and Physician Transactions
Transaction Healthcare
Gary Herschman is a Member of Epstein Becker & Green, P.C., a firm specializing in healthcare and life sciences, where Gary co-chairs the healthcare transactions and M&A group. With over 30 years of experience in healthcare M&A, he represents hospitals, ASCs, physician groups, and home healthcare companies in consolidations, affiliations, joint ventures, physician alignments, and more. Among his many accolades, Gary has been listed in The Best Lawyers in America for Health Care Law from 2010 to 2025 and was named a 2024 Leader in Law by NJBIZ. In this episode… Navigating...
info_outlineDusty Majumdar is the CEO of PredxBio, a precision pathology company leveraging AI and spatial biology to transform cancer diagnostics and therapeutics. With over two decades of leadership experience in precision healthcare, he has held senior roles at the American Society of Clinical Oncology, IBM, Exact Sciences, and GE Healthcare. Dusty has spoken at numerous forums, including The Economist War on Cancer and a MIT plenary lecture on AI in healthcare.
In this episode…
Despite recent advances in cancer research, early detection and effective treatment remain major challenges. Traditional diagnostic tools often fail to fully capture the complex biological interactions driving tumor growth and therapy resistance. How can emerging technologies like AI and spatial biology help personalize cancer care and improve patient outcomes?
Spatial biology and AI can decode the tumor microenvironment at a much deeper level than genomics alone. By analyzing how cells organize and communicate within tumors, this approach can predict therapy responses with over 90% accuracy. Oncology, genomics, and AI-driven healthcare leader Dusty Majumdar emphasizes the importance of integrating multi-omic data, such as proteomics, transcriptomics, and metabolomics, to personalize treatment strategies. He envisions a future where virtual clinical trials drastically reduce development time and costs while improving trial success rates.
Tune in to this episode of Transaction Healthcare as host Zak Eisenberg chats with Dusty Majumdar, CEO of PredxBio, about using AI and spatial biology to transform oncology care. Dusty talks about liquid biopsy limitations, the role of regulatory bodies like the FDA, and the evolution of AI in healthcare.